{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:26:04Z","timestamp":1787901964230,"version":"build-2784847793"},"reference-count":49,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>X linked Charcot-Marie-Tooth disease (CMTX) is a hereditary neuropathy caused by mutations in <jats:italic>GJB1<\/jats:italic> coding for connexin-32, a gap junction protein expressed in Schwann cells, but also found in oligodendrocytes. Four patients with CMTX developing central nervous system (CNS) demyelination compatible with multiple sclerosis (MS) have been individually published. We presently sought to systematically investigate the relationship between CMTX and MS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Over 20 years, 70 consecutive patients (36 men) with <jats:italic>GJB1<\/jats:italic> mutations were identified at our Neurogenetics Unit, Athens, Greece, and assessed for clinical features suggestive of MS. Additionally, 18 patients with CMTX without CNS symptoms and 18 matched controls underwent brain MRI to investigate incidental findings. Serum from patients with CMTX and MS was tested for CNS immunoreactivity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified three patients with CMTX who developed clinical features suggestive of inflammatory CNS demyelination fulfilling MS diagnostic criteria. The resulting 20-year MS incidence (4.3%) differed significantly from the highest background 20-year MS incidence ever reported from Greece (p=0.00039). The search for incidental brain MRI findings identified two CMTX cases (11%) with lesions suggestive of focal demyelination compared with 0 control. Moreover, 10 cases in the CMTX cohort had hyperintensity in the splenium of the corpus callosum compared with 0 control (p=0.0002). No specific CNS-reactive humoral factors were identified in patients with CMTX and MS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We have demonstrated a higher than expected frequency of MS in patients with CMTX and identified incidental focal demyelinating lesions on brain MRI in patients with CMTX without CNS symptoms. This provides circumstantial evidence for <jats:italic>GJB1<\/jats:italic> mutations acting as a possible MS risk factor.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jnnp-2018-319014","type":"journal-article","created":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T16:15:22Z","timestamp":1536423322000},"page":"187-194","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["X linked Charcot-Marie-Tooth disease and multiple sclerosis: emerging evidence for an association"],"prefix":"10.1136","volume":"90","author":[{"given":"Georgios","family":"Koutsis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianthi","family":"Breza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Velonakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kasselimis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrisoula","family":"Kartanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Karavasilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Tzanetakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Anagnostouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisavet","family":"Andreadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Eleftheria","family":"Evangelopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Kilidireas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Potagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Panas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Karadima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,9,8]]},"reference":[{"key":"2020050722330887000_90.2.187.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.179"},{"key":"2020050722330887000_90.2.187.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1401483"},{"key":"2020050722330887000_90.2.187.3","doi-asserted-by":"publisher","DOI":"10.1385\/NMM:8:1:107"},{"key":"2020050722330887000_90.2.187.4","doi-asserted-by":"crossref","unstructured":"Cortese R , Zoccolella S , Muglia M , et al . A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B. Brain Behav 2016;6:e00580.doi:10.1002\/brb3.580","DOI":"10.1002\/brb3.580"},{"key":"2020050722330887000_90.2.187.5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.24824","article-title":"Cerebral white matter abnormalities in patients with charcot-marie-tooth disease","volume":"81","author":"Lee","year":"2017","journal-title":"Ann Neurol"},{"key":"2020050722330887000_90.2.187.6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.66.2.202"},{"key":"2020050722330887000_90.2.187.7","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10305"},{"key":"2020050722330887000_90.2.187.8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.10.1906"},{"key":"2020050722330887000_90.2.187.9","doi-asserted-by":"crossref","first-page":"413a","DOI":"10.1136\/jnnp.63.3.413a","article-title":"Multiple sclerosis associated with duplicated CMT1A: a report of two cases","volume":"63","author":"Frasson","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2020050722330887000_90.2.187.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(98)00016-9"},{"key":"2020050722330887000_90.2.187.11","first-page":"1","article-title":"Central nervous system demyelination in a Charcot-Marie-Tooth type 1A patient","volume":"2013","author":"Koros","year":"2013","journal-title":"Case Rep Neurol Med"},{"key":"2020050722330887000_90.2.187.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1085-9489.2005.00054.x"},{"key":"2020050722330887000_90.2.187.13","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.225"},{"key":"2020050722330887000_90.2.187.14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5114\/fn.2012.32366","article-title":"Charcot-Marie-Tooth type 1C disease coexisting with progressive multiple sclerosis: a study of an overlapping syndrome","volume":"50","author":"Potulska-Chromik","year":"2012","journal-title":"Folia Neuropathol"},{"key":"2020050722330887000_90.2.187.15","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000186032.06791.94"},{"key":"2020050722330887000_90.2.187.16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00415-006-0324-7","article-title":"X-linked Charcot-Marie-Tooth disease and multiple sclerosis","volume":"254","author":"Parman","year":"2007","journal-title":"J Neurol"},{"key":"2020050722330887000_90.2.187.17","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00415-012-6467-9","article-title":"Inflammatory demyelinating CNS disorder in a case of X-linked Charcot-Marie-Tooth disease: positive response to natalizumab","volume":"259","author":"Weishaupt","year":"2012","journal-title":"J Neurol"},{"key":"2020050722330887000_90.2.187.18","first-page":"1","article-title":"Relapsing remitting multiple sclerosis in x-linked charcot-marie-tooth disease with central nervous system involvement","volume":"2015","author":"Koutsis","year":"2015","journal-title":"Case Rep Neurol Med"},{"key":"2020050722330887000_90.2.187.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.04.007"},{"key":"2020050722330887000_90.2.187.20","doi-asserted-by":"crossref","first-page":"947a","DOI":"10.1136\/jnnp.65.6.947a","article-title":"Central nervous system involvement in four patients with Charcot-Marie-Tooth disease with connexin 32 extracellular mutations","volume":"65","author":"Panas","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2020050722330887000_90.2.187.21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00415-005-0955-0","article-title":"Four novel connexin 32 mutations in X-linked Charcot-Marie-Tooth disease with phenotypic variability","volume":"253","author":"Karadima","year":"2006","journal-title":"J Neurol"},{"key":"2020050722330887000_90.2.187.22","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000335764.14513.1a"},{"key":"2020050722330887000_90.2.187.23","doi-asserted-by":"crossref","unstructured":"Waters P , Woodhall M , O'Connor KC , et al . MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2015;2:e89.doi:10.1212\/NXI.0000000000000089","DOI":"10.1212\/NXI.0000000000000089"},{"key":"2020050722330887000_90.2.187.24","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"2020050722330887000_90.2.187.25","doi-asserted-by":"publisher","DOI":"10.1159\/000122334"},{"key":"2020050722330887000_90.2.187.26","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.187"},{"key":"2020050722330887000_90.2.187.27","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh017"},{"key":"2020050722330887000_90.2.187.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2012.01140.x"},{"key":"2020050722330887000_90.2.187.29","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ene.12759","article-title":"Antibody biomarkers in CNS demyelinating diseases - a long and winding road","volume":"22","author":"Berger","year":"2015","journal-title":"Eur J Neurol"},{"key":"2020050722330887000_90.2.187.30","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.260"},{"key":"2020050722330887000_90.2.187.31","first-page":"44","article-title":"Central motor and sensory pathway involvement in an X-linked Charcot-Marie-Tooth family","volume":"108","author":"Zambelis","year":"2008","journal-title":"Acta Neurol Belg"},{"key":"2020050722330887000_90.2.187.32","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000038390.29853.46"},{"key":"2020050722330887000_90.2.187.33","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.4.605"},{"key":"2020050722330887000_90.2.187.34","doi-asserted-by":"crossref","unstructured":"van Paassen BW , van der Kooi AJ , van Spaendonck-Zwarts KY , et al . PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies. Orphanet J Rare Dis 2014;9:38.doi:10.1186\/1750-1172-9-38","DOI":"10.1186\/1750-1172-9-38"},{"key":"2020050722330887000_90.2.187.35","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303725"},{"key":"2020050722330887000_90.2.187.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-012-0978-4"},{"key":"2020050722330887000_90.2.187.37","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22334"},{"key":"2020050722330887000_90.2.187.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2010.11.009"},{"key":"2020050722330887000_90.2.187.39","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.10255"},{"key":"2020050722330887000_90.2.187.40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40478-016-0369-5","article-title":"Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease","volume":"4","author":"Olympiou","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"2020050722330887000_90.2.187.41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10048-015-0442-4","article-title":"A start codon CMT1X mutation associated with transient encephalomyelitis causes complete loss of Cx32","volume":"16","author":"Sargiannidou","year":"2015","journal-title":"Neurogenetics"},{"key":"2020050722330887000_90.2.187.42","doi-asserted-by":"crossref","unstructured":"Abrams CK , Goman M , Wong S , et al . Loss of coupling distinguishes GJB1 mutations associated with CNS manifestations of CMT1X from those without CNS manifestations. Sci Rep 2017;7:40166.doi:10.1038\/srep40166","DOI":"10.1038\/srep40166"},{"key":"2020050722330887000_90.2.187.43","doi-asserted-by":"publisher","DOI":"10.1177\/0883073815604227"},{"key":"2020050722330887000_90.2.187.44","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.46.0047"},{"key":"2020050722330887000_90.2.187.45","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000158329.30470.D0"},{"key":"2020050722330887000_90.2.187.46","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3653"},{"key":"2020050722330887000_90.2.187.47","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-012-0972-x"},{"key":"2020050722330887000_90.2.187.48","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1212\/WNL.0000000000003819","article-title":"Mutations in noncoding regions of GJB1 are a major cause of X-linked CMT","volume":"88","author":"Tomaselli","year":"2017","journal-title":"Neurology"},{"key":"2020050722330887000_90.2.187.49","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.0000000000004296","article-title":"Cross-sectional analysis of a large cohort with X-linked Charcot-Marie-Tooth disease (CMTX1)","volume":"89","author":"Panosyan","year":"2017","journal-title":"Neurology"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2018-319014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T18:12:42Z","timestamp":1601057562000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2018-319014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,8]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,1,16]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1136\/jnnp-2018-319014"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2018-319014","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,8]]}}}